Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer

2015 ◽  
Vol 22 (9) ◽  
pp. 669-674 ◽  
Author(s):  
Toshikazu Moriwaki ◽  
Hiroyasu Ishida ◽  
Masahiro Araki ◽  
Shinji Endo ◽  
Shigemasa Yoshida ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Phase I ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Phase I Study ◽  
Tract Cancer

scholarly journals A Phase I Study of Gemcitabine (Gem), Cisplatin (Cddp), and S-1 Combination in Untreated Patients (Pts) with Advanced Biliary Tract Cancer (Abtc)

2014 ◽  
Vol 25 ◽  
pp. iv245
Author(s):  
T. Moriwaki ◽  
H. Ishida ◽  
M. Araki ◽  
S. Endo ◽  
S. Yoshida ◽  
...  
Keyword(s):  
Phase I ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Phase I Study ◽  
Tract Cancer

A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer

Brachytherapy ◽  
2015 ◽  
Vol 14 (3) ◽  
pp. 401-404 ◽  
Author(s):  
Gian Carlo Mattiucci ◽  
Rosa Autorino ◽  
Andrea Tringali ◽  
Vincenzo Perri ◽  
Mario Balducci ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Rate ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Phase I Study ◽  
Palliative Treatment ◽  
High Dose Rate ◽  
High Dose ◽  
Tract Cancer ◽  
Intraluminal Brachytherapy

scholarly journals Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer

2017 ◽  
Vol 6 (5) ◽  
pp. 753-757 ◽  
Author(s):  
Hidehiro Tajima ◽  
Tetsuo Ohta ◽  
Hiroyuki Shinbashi ◽  
Atsushi Hirose ◽  
Mitsuyoshi Okazaki ◽  
...  
Keyword(s):  
Phase I ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Phase I Study ◽  
Low Dose ◽  
Palliative Chemotherapy ◽  
Tract Cancer ◽  
Third Line

scholarly journals Phase I study of nivolumab or nivolumab/cisplatin/gemcitabine to treat unresectable/recurrent biliary tract cancer

2019 ◽  
Vol 30 ◽  
pp. vi86-vi87
Author(s):  
Chigusa Morizane ◽  
Masafumi Ikeda ◽  
Makoto Ueno ◽  
Satoshi Kobayashi ◽  
Izumi Ohno ◽  
...  
Keyword(s):  
Phase I ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Phase I Study ◽  
Tract Cancer

scholarly journals A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study

2012 ◽  
Vol 31 (4) ◽  
pp. 943-948 ◽  
Author(s):  
Noelle K. LoConte ◽  
Kyle D. Holen ◽  
William R. Schelman ◽  
Daniel L. Mulkerin ◽  
Dustin A. Deming ◽  
...  
Keyword(s):  
Phase I ◽  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Phase I Study ◽  
High Dose ◽  
Tract Cancer
Sign in / Sign up

Export Citation Format

Share Document